Serum midkine depends on lymph node involvement and correlates with circulating VEGF-C in oesophageal squamous cell carcinoma

References

• Bollschweiler E, Baldus SE, Schroder W, Prenzel K, Gutschow C, Schneider PM, Holscher AH. High rate of lymph-node metastasis in submucosal esophageal squamous-cell carcinomas and adenocarcinomas. Endoscopy 2006; 38: 149–156
   PubMed Web of Science ®Google Scholar
• Enzinger PC, Mayer RJ. Medical Progress: Esophageal Cancer. New England Journal of Medicine 2003; 349: 2241–2252
   PubMed Web of Science ®Google Scholar
• Green FL, Page DL, Fleming ID, Fritz A, Balch ChM, Haller DG, Morrow M. AJCC Cancer Staging Manual6th edn. Springer Verlag, New York 2002
   Google Scholar
• Ikematsu S, Nakagawara A, Nakamura Y, Sakuma S, Wakai K, Muramatsu T, Kadomatsu K. Correlation of elevated level of blood midkine with poor prognostic factors of human neuroblastomas. British Journal of Cancer 2003; 88: 1522–1526
   PubMed Web of Science ®Google Scholar
• Kadomatsu K, Muramatsu T. Midkine and pleiotrophin in neural development and cancer. Cancer Letters 2004; 204: 127–143
   PubMed Web of Science ®Google Scholar
• Klinger MH, Jelkmann W. Role of blood platelets in infection and inflammation. Journal of Interferon & Cytokine Research 2002; 22: 913–922
   PubMed Web of Science ®Google Scholar
• Konishi N, Nakamura M, Nakaoka S, Hiasa Y, Cho M, Uemura H, Hirao Y, Muramatsu T, Kadomatsu K. Immunohistochemical analysis of midkine expression in human prostate carcinoma. Oncology 1999; 57: 253–257
   PubMed Web of Science ®Google Scholar
• Krzystek-Korpacka M, Matusiewicz M, Grabowski K, Diakowska D, Boehm D, Kustrzeba-Wojcicka I, Banas T. Immunoenzymatic method for midkine determination in serum. Advances in Clinical & Experimental Medicine 2006; 15: 247–252
   Google Scholar
• Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Banas T. Up-regulation of VEGF-C secreted by cancer cells and not VEGF-A correlates with clinical evaluation of lymph node metastasis in esophageal squamous cell carcinoma (ESCC). Cancer Letters 2007; 249: 171–177
   PubMed Web of Science ®Google Scholar
• Kuwano H, Kato H, Miyazaki T, Fukuchi M, Masuda N, Nakajima M, Fukai Y, Sohda M, Kimura H, Faried A. Genetic alterations in esophageal cancer. Surgery Today 2005; 35: 7–18
   PubMed Web of Science ®Google Scholar
• Mitsuhashi A, Suzuka K, Yamazawa K, Matsui H, Seki K, Sekiya S. Serum vascular endothelial growth factor (VEGF) and VEGF-C levels as tumor markers in patients with cervical carcinoma. Cancer 2005; 103: 724–730
   PubMed Web of Science ®Google Scholar
• Mukai M, Sato S, Nakasaki H, Tajima T, Saito Y, Nishiumi N, Iwasaki M, Tokuda Y, Ogoshi K, Inoue H, Makuuchi H. Occult neoplastic cells in the lymph node sinuses and recurrence of primary breast, lung, esophageal, and gastric cancer. Oncology Reports 2004; 11: 81–84
   PubMed Web of Science ®Google Scholar
• Muramatsu T. Midkine and pleiotrophin: two related proteins involved in development, survival, inflammation and tumorigenesis. Journal of Biochemistry 2002; 132: 359–371
   PubMed Web of Science ®Google Scholar
• Natsugoe S, Mueller J, Stein H, Feith M, Hofler H, Siewert JR. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma. Cancer 1998; 83: 858–866
   PubMed Web of Science ®Google Scholar
• Nomiya T, Nemoto K, Miyachi H, Fujimoto K, Takahashi C, Takeda K, Matushita H, Ogawa Y, Takai Y, Yamada S. Significance of plasminogen-activation system in the formation of macroscopic types and invasion in esophageal carcinoma. Anticancer Research 2002; 22: 2913–2916
   PubMed Web of Science ®Google Scholar
• Parkin DM, Bray F, Ferlay J, Pisani P. Global Cancer Statistics, 2002. CA: A Cancer Journal for Clinicians 2005; 55: 74–108
   PubMed Web of Science ®Google Scholar
• Ren YJ, Zhang QY. Expression of midkine and its clinical significance in esophageal squamous cell carcinoma. World Journal of Gastroenterology 2006; 12: 2006–2010
   PubMed Web of Science ®Google Scholar
• Salama RH, Muramatsu H, Zhou P, Okayama M, Muramatsu T. Midkine, a heparin-binding growth factor, produced by the host enhances metastasis of Lewis lung carcinoma cells. Cancer Letters 2006; 233: 16–20
   PubMed Web of Science ®Google Scholar
• Sato T, Iizuka N, Hamamoto Y, Yoshino S, Abe T, Takeda S, Uchimura S, Miyamoto T, Sei F, Hamada K, Yamada-Okabe H, Oka M. Esophageal squamous cell carcinomas with distinct invasive depth show different gene expression profiles associated with lymph node metastasis. International Journal of Oncology 2006; 28: 1043–1055
   PubMed Web of Science ®Google Scholar
• Shimada H, Nabeya Y, Mastubara H, Okazumi S, Shiratori T, Shimizu T, Aoki T, Shuto K, Akutsu Y, Ochiai T. Prediction of lymph node status in patients with superficial esophageal carcinoma: analysis of 160 surgically resected cancers. American Journal of Surgery 2006; 91: 250–254
   Google Scholar
• Shimada H, Nabeya Y, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T. Increased serum midkine concentration as a possible tumor marker in patients with superficial esophageal cancer. Oncology Report 2003a; 10: 411–414
   PubMed Web of Science ®Google Scholar
• Shimada H, Nabeya Y, Tagawa M, Okazumi S, Matsubara H, Kadomatsu K, Muramatsu T, Ikematsu S, Sakuma S, Ochiai T. Preoperative serum midkine concentration is a prognostic marker for esophageal squamous cell carcinoma. Cancer Science 2003b; 94: 628–632
   PubMed Web of Science ®Google Scholar
• Sobin LH, Wittekind Ch. TNM Classification of Malignant Tumors6th edn. Jon Wiley & Sons, Hoeboken, New Jersey 2002
   Google Scholar
• Soulie P, Heroult M, Bernard-Pierrot I, Caruelle D, Oglobine J, Barritault D, Courty J. Correlation of elevated plasma levels of two structurally related growth factors, heparin affin regulatory peptide and midkine, in advanced solid tumor patients. Cancer Detection & Prevention 2004; 28: 319–324
   PubMedGoogle Scholar
• Tamura M, Oda M, Tsunezuka Y, Matsumoto I, Kawakami K, Ohta Y, Watanabe G. Chest CT and serum vascular endothelial growth factor-C level to diagnose lymph node metastasis in patients with primary non-small cell lung cancer. Chest 2004; 126: 342–346
   PubMed Web of Science ®Google Scholar